Targeted therapy for colorectal cancer
- VernacularTitle:大肠癌靶向治疗进展
- Author:
Li ZHANG
;
Zhiqiang WANG
- Publication Type:Journal Article
- Keywords:
colorectal cancer;
targeted therapy;
bevacizumab;
cetuximab
- From:China Oncology
1998;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Colorectal cancer is one of the most common malignant tumors. The recent successful development of targeted therapy has brought new hope for patients with colorectal cancer. Two monoclonal antibodies, bevacizumab and cetuximab, that block vascular endothelial growth factor and epithelial growth factor receptor are available widely in clinical practice. This clinical review focuses on the role of targeted therapy in the management of colorectal cancer.
